Development of High-Energy Anodes for All-Solid-State Lithium Batteries Based on Sulfide Electrolytes.

All-solid-state Li batteries (ASSBs) promise better performance and higher safety than the current liquid-based Li-ion batteries (LIBs). Sulfide ASSBs have been extensively studied and considerably advanced in recent decades. Research on identifying suitable cathode materials for sulfide ASSBs is currently well established, with great progress being made in the commercialization of layered cathodes in the liquid-based LIBs. Research on anode materials for sulfide ASSBs is of great importance for enhancing the battery energy density. However, it seems that little has been published that summarizes studies of anode materials for sulfide ASSBs and suggests future research directions. Thus, within this Minireview, we aim to provide an overview of previous and current research focused on anode materials for sulfide ASSBs and to suggest a future research direction for developing suitable anode systems for sulfide ASSBs.

Protective effect of ellagic acid on concanavalin A-induced hepatitis via toll-like receptor and mitogen-activated protein kinase/nuclear factor κB signaling pathways.

Ellagic acid (EA) is present in certain fruits and nuts, including raspberries, pomegranates, and walnuts, and has anti-inflammatory and antioxidant properties. The aims of this study were to examine the protective effect of EA on concanavalin A (Con A)-induced hepatitis and to elucidate its underlying molecular mechanisms in mice. Mice were orally administered EA at different doses before the intravenous delivery of Con A; the different experimental groups were as follows: (i) vehicle control, (ii) Con A alone without EA, (iii) EA at 50 mg/kg, (iv) EA at 100 mg/kg, and (v) EA at 200 mg/kg. We found that EA pretreatment significantly reduced the levels of plasma aminotransferase and liver necrosis in Con A-induced hepatitis. Also, EA significantly decreased the expression levels of the toll-like receptor 2 (TLR2) and TLR4 mRNA and protein in liver tissues. Further, EA decreased the phosphorylation of JNK, ERK1/2, and p38. EA-treated groups showed suppressions of nuclear factor κB (NF-κB) and IκB-α degradation levels in liver tissues. In addition, EA pretreatment decreased the expression of pro-inflammatory cytokines, such as tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and interleukin 1ß (IL-1ß). These results suggest that EA protects against T-cell-mediated hepatitis through TLR and mitogen-activated protein kinase (MAPK)/NF-κB signaling pathways.